Alvogen Reshaped By A Year Of Change

Group Positioned For Future By Sale Of CEE Business And Adalvo B2B Rebranding

After a year that has seen Alvogen divest its central and eastern Europe business to Zentiva and rebrand its B2B unit as Adalvo, the group has also demonstrated the resilience of its supply chain in the face of upheaval caused by the coronavirus pandemic, chairman and CEO Robert Wessman tells Generics Bulletin in the second part of an exclusive interview.

2020 Workmen
This year has seen several changes for Alvogen • Source: Shutterstock

Alvogen group has experienced a number of key changes in 2020. It divested its central and eastern European business to Zentiva in a major transaction (Also see "Alvogen And Zentiva Complete CEE Deal" - Generics Bulletin, 20 April, 2020.); it rebranded its business-to-business unit with a new name and identity as Adalvo (Also see "Alvogen Group Unveils Adalvo B2B Unit" - Generics Bulletin, 4 June, 2020.); and, like all firms, it has grappled with the pressures of an unpredictable coronavirus pandemic that posed a potential threat to supply-chain security.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

More from Business